{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:46:25Z","timestamp":1773247585757,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00520-021-06350-2","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T18:02:52Z","timestamp":1623780172000},"page":"7611-7616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gabapentin enhances the antinociceptive effect of intrathecal morphine in refractory cancer pain patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Lei","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxue","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8976-0262","authenticated-orcid":false,"given":"Huichao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"issue":"9","key":"6350_CR1","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen MH et al (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437\u20131449","journal-title":"Ann Oncol"},{"key":"6350_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.sjpain.2016.10.002","volume":"14","author":"TC Mastenbroek","year":"2017","unstructured":"Mastenbroek TC et al (2017) Multimodal intrathecal analgesia in refractory cancer pain. Scand J Pain 14:39\u201343","journal-title":"Scand J Pain"},{"issue":"6","key":"6350_CR3","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1213\/ANE.0000000000002903","volume":"126","author":"G Carvajal","year":"2018","unstructured":"Carvajal G et al (2018) Intrathecal Drug delivery systems for refractory pancreatic cancer pain: observational follow-up study over an 11-year period in a comprehensive cancer center. Anesth Analg 126(6):2038\u20132046","journal-title":"Anesth Analg"},{"issue":"5","key":"6350_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/annonc\/mdi156","volume":"16","author":"TJ Smith","year":"2005","unstructured":"Smith TJ et al (2005) An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol 16(5):825\u2013833","journal-title":"Ann Oncol"},{"issue":"4","key":"6350_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bpa.2017.05.003","volume":"31","author":"P Lavand\u2019homme","year":"2017","unstructured":"Lavand\u2019homme P, Steyaert A (2017) Opioid-free anesthesia opioid side effects: tolerance and hyperalgesia. Best Pract Res Clin Anaesthesiol 31(4):487\u2013498","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"2","key":"6350_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.21037\/atm-20-3814","volume":"9","author":"MA Capozza","year":"2021","unstructured":"Capozza MA et al (2021) Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications. Ann Transl Med 9(2):186","journal-title":"Ann Transl Med"},{"issue":"Suppl 10","key":"6350_CR7","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/AJP.0b013e31816b5976","volume":"24","author":"BE McGeeney","year":"2008","unstructured":"McGeeney BE (2008) Adjuvant agents in cancer pain. Clin J Pain 24(Suppl 10):S14-20","journal-title":"Clin J Pain"},{"issue":"6","key":"6350_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00540-017-2406-3","volume":"31","author":"T Kiatchai","year":"2017","unstructured":"Kiatchai T et al (2017) Effects of pregabalin on postoperative pain after hysterectomy under spinal anesthesia with intrathecal morphine: a randomized controlled trial. J Anesth 31(6):861\u2013868","journal-title":"J Anesth"},{"key":"6350_CR9","doi-asserted-by":"crossref","unstructured":"Jiang Y et al (2018)\u00a0The efficacy of gabapentin in reducing pain intensity and morphine consumption after breast cancer surgery: a meta-analysis. Medicine (Baltimore) 97(38): e11581","DOI":"10.1097\/MD.0000000000011581"},{"issue":"7","key":"6350_CR10","first-page":"649","volume":"20","author":"C Han","year":"2017","unstructured":"Han C et al (2017) The efficacy of preoperative gabapentin in spinal surgery: a meta-analysis of randomized controlled trials. Pain Physician 20(7):649\u2013661","journal-title":"Pain Physician"},{"issue":"19","key":"6350_CR11","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","volume":"20","author":"TJ Smith","year":"2002","unstructured":"Smith TJ et al (2002) Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 20(19):4040\u20134049","journal-title":"J Clin Oncol"},{"issue":"5","key":"6350_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1055\/s-0036-1584950","volume":"36","author":"J Gierthm\u00fchlen","year":"2016","unstructured":"Gierthm\u00fchlen J, Baron R (2016) Neuropathic pain. Semin Neurol 36(5):462\u2013468","journal-title":"Semin Neurol"},{"issue":"3","key":"6350_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12272-013-0057-y","volume":"36","author":"A Kukkar","year":"2013","unstructured":"Kukkar A et al (2013) Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res 36(3):237\u2013251","journal-title":"Arch Pharm Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06350-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06350-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06350-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T12:25:23Z","timestamp":1635251123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06350-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6350"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06350-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]},"assertion":[{"value":"17 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Institutional Review Board of Harbin Medical University Cancer Hospital. Written informed consent for participation was obtained from patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read this manuscript and would like to have it considered exclusively for publication in Supportive Care in Cancer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}